Our @Point of Care Cardiology Podcasts have healthcare experts discussing and providing information related to cardiology diagnosis, treatment, management, and other important information.
S7:E2 – Keeping Up With the Times: Navigating the 2026 Treatment Landscape
In this episode, Keeping Up With the Times - Navigating the 2026 ATTR-CM Treatment Landscape, nurse practitioner Tracy Joshi and Dr. Akshay Desai take a deep dive into the treatment options for this disease. They will discuss the therapies now available and will look at stabilization and silencing strategies. This discussion will help you distinguish between the agents so that you can optimize your patient’s care.
Visit https://suiteweb.atpointofcare.com/#library/amyloidosis/2731.12/page/0 (https://suiteweb.atpointofcare.com/#library/amyloidosis/2731.12/page/0) to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.
7 May 2026
S7:E1 – Stop the Clock - Identifying ATTR-CM Before Function is Lost
In this episode, Stop the Clock - Identifying ATTR-CM Before Function is Lost, nurse practitioner Tracy Joshi and Dr. Akshay Desai focus their discussion on how ATTR-CM presents in clinic, who should be screened using diagnostic algorithms, and most importantly, the benefits of early intervention for this patient population.
Visit https://suiteweb.atpointofcare.com/#library/amyloidosis/2731.11/page/0 (https://suiteweb.atpointofcare.com/#library/amyloidosis/2731.11/page/0) to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.
15 May 2025
S6:E2 – Best Practices for ATTR-CM Management
In this episode, our Faculty, Dr. Nitasha Sarswat and Dr. Michelle Kittleson, discuss how biomarkers come into play for the diagnosis of transthyretin amyloid cardiomyopathy, or ATTR-CM. They will also discuss the latest therapeutic landscape, what the latest trial data show, and what’s in the pipeline.
Visit https://suitehome.atpointofcare.com/library/2684.12/page/0?subdomain=amyloidosis (https://suitehome.atpointofcare.com/library/2684.12/page/0?subdomain=amyloidosis) to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.
This podcast is powered by Pinecast (https://pinecast.com).
15 May 2025
S6:E1 – Don't Miss This: A Clinician's Call to Greater ATTR-CM Awareness and Early Diagnosis
In this episode, our Faculty, Dr. Nitasha Sarswat and Tracy Joshi, DNP, discuss the often misdiagnosed condition transthyretin amyloid cardiomyopathy. What are the diagnostic red flags clinicians should be aware of, and what diagnostic tools are helpful to ensure their patients get the right diagnosis?
Visit https://suitehome.atpointofcare.com/library/2684.11/page/0?subdomain=amyloidosis (https://suitehome.atpointofcare.com/library/2684.11/page/0?subdomain=amyloidosis) to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.
This podcast is powered by Pinecast (https://pinecast.com).
30 Apr 2025
S5:E2 – Precision Medicine in IBD
In this episode, Precision Medicine in IBD, Dr. Bruce Sands and Dr. Marla Dubinsky take a look at precision medicine in treating irritable bowel disease (IBD), what comprises this approach to care, and how can clinicians best implement it into the day-to-day care of their patients with IBD.
Visit https://suiteweb.atpointofcare.com/#library/ibd/2675.02/page/0 (https://suiteweb.atpointofcare.com/#library/ibd/2675.02/page/0) to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.
This podcast is powered by Pinecast (https://pinecast.com).
30 Apr 2025
S5:E1 – Breaking Tradition for Proactive Approaches to IBD Care
In this episode, Breaking Tradition for Proactive Approaches to IBD Care, Dr. Bruce Sands and Dr. Marla Dubinsky discuss the importance of early intervention and treating to target. How can clinicians optimize treatment for their patients with irritable bowel disease (IBD) so they achieve the best possible outcomes?
Visit https://suiteweb.atpointofcare.com/#library/ibd/2675.01/page/0 (https://suiteweb.atpointofcare.com/#library/ibd/2675.01/page/0) to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.
This podcast is powered by Pinecast (https://pinecast.com).
15 Aug 2024
S4:E2 – Attractive Therapies on the Horizon for ATTR-CM
Visit Attractive Therapies on the Horizon for ATTR-CM (https://suiteweb.atpointofcare.com/#library/amyloidosis/2649.12/page/0) to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.
In this episode our faculty discuss some of the recent developments in the therapeutic landscape, and look at some exciting presentations coming out of the 2024 International Symposium on Amyloidosis.
15 Aug 2024
S4:E1 – The Clock Is Ticking on ATTR-CM
Visit The Clock Is Ticking on ATTR-CM (https://suiteweb.atpointofcare.com/#library/amyloidosis/2649.11/page/0) to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.
In this episode our faculty discuss the clinical manifestations and how to correctly diagnosis transthyretin amyloid cardiomyopathy (ATTR-CM). What should clinicians know in order to make an accurate and timely diagnosis?
28 Mar 2022
S3:E6 – Heart Failure Morning Commute: Decisions in the Management of Heart Failure
When should heart failure therapies be combined, switched, or stopped? Our faculty discuss this topic as well as how Covid-19 has impacted heart failure treatment.
Visit www.morningcommutepodcast.com/heartfailure6 (http://www.morningcommutepodcast.com/heartfailure6) to view the activity and CME/CE information, download the transcript, and complete the post-test and evaluation to earn CME/CE credit
1 Mar 2022
S3:E5 – Heart Failure Morning Commute: More Heart Failure Drugs, More Choices
With the many therapies that are now available for the treatment of heart failure, who are the best candidates for these medications and what are the potential side effects? Our faculty discuss this and more.
Visit www.morningcommutepodcast.com/heartfailure5 (http://www.morningcommutepodcast.com/heartfailure5) to view the activity and CME/CE information, download the transcript, and complete the post-test and evaluation to earn CME/CE credit
1 Mar 2022
S3:E4 – Heart Failure Morning Commute: Managing Heart Failure in Patients With Type 2 Diabetes
In this podcast our faculty discuss treating patients who have diabetes and heart failure and the remarkable story of SGLT-2 inhibitors for this patient population.
Visit www.morningcommutepodcast.com/heartfailure4 (http://www.morningcommutepodcast.com/heartfailure4) to view the activity and CME/CE information, download the transcript, and complete the post-test and evaluation to earn CME/CE credit
28 Feb 2022
S3:E3 – Heart Failure Morning Commute: Preventing Heart Failure in High-Risk Patients With Type 2 Diabetes
How should the patient with diabetes who is at risk of developing heart failure be managed? What medication is needed and how important is prevention through diet and exercise?
Visit www.morningcommutepodcast.com/heartfailure3 (http://www.morningcommutepodcast.com/heartfailure3) to view the activity and CME/CE information, download the transcript, and complete the post-test and evaluation to earn CME/CE credit
28 Feb 2022
S3:E2 – Heart Failure Morning Commute: Managing Patients With Mid-Range or Preserved EF
What are the current guidelines for managing patients with heart failure and why are heart failure labels so confusing? Our faculty help decipher these and more in this podcast episode.
Visit www.morningcommutepodcast.com/heartfailure2 (http://www.morningcommutepodcast.com/heartfailure2) to view the activity and CME/CE information, download the transcript, and complete the post-test and evaluation to earn CME/CE credit
28 Feb 2022
S3:E1 – Heart Failure Morning Commute: Patient Diagnosis and Subtype Classification of Heart Failure
In this podcast our faculty discuss diagnosing the heart failure patient in the primary care setting. What should the process be for making this diagnosis and how important is taking a complete medical and family history?
Visit www.morningcommutepodcast.com/heartfailure1 (http://www.morningcommutepodcast.com/heartfailure1) to view the activity and CME/CE information, download the transcript, and complete the post-test and evaluation to earn CME/CE credit
30 Mar 2021
S2:E3 – SGLT-2 Inhibitors Morning Commute: A Clinical Pathway for Action
Visit http://morningcommutepodcast.com/SGLT2inhibitors6 (http://morningcommutepodcast.com/SGLT2inhibitors6) to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. In this episode, Dr. James Januzzi and Dr. Silvio Inzucchi discuss the surge in collaboration between primary care physicians, endocrinologists, and cardiologists and the groundswell of cardiometabolic clinics. They attribute this to cardiologists moving beyond the so-called glucocentric view and focusing on how diabetes therapies might help reduce cardiovascular risk as well. Drs. Januzzi and Inzucchi will also discuss the recent guidelines that now incorporate sodium-glucose cotransporter 2 (SGLT-2) inhibitors into clinical pathways.
30 Mar 2021
S2:E2 – SGLT-2 Inhibitors Morning Commute: The Heart Failure Connection
Visit http://morningcommutepodcast.com/SGLT2inhibitors5 (http://morningcommutepodcast.com/SGLT2inhibitors5) to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. In this episode Dr. James Januzzi and Dr. Silvio Inzucchi discuss how sodium-glucose cotransporter 2 (SGLT-2) inhibitors evolved from treatments for type 2 diabetes mellitus (T2DM) to key treatments for patients with heart failure. Drs. Januzzi and Inzucchi look at the pivotal trials that thrust these treatments into the heart failure treatment limelight.
Visit http://morningcommutepodcast.com/SGLT2inhibitors4 (http://morningcommutepodcast.com/SGLT2inhibitors4) to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. In this episode Dr. James Januzzi and Dr. Silvio Inzucchi will discuss SGLT-2 inhibition in cardiovascular risk reduction by taking a look at some of the pivotal clinical trial data.
15 Feb 2021
S1:E2 – Cardiology Journal Club: Treating the Pandemic Heart
The Covid-19 pandemic has hit patients with cardiovascular disease particularly hard. Moreover, cardiovascular disease sequelae are plaguing Covid-19 patients who did not have heart disease to begin with. Our faculty discusses several papers related to cardiology issues as well as what they are seeing in their own clinics.
22 Dec 2020
S1:E1 – Cardiology Journal Club: Special Considerations in Covid-19 and Coagulopathy Risks
Visit http://journalclubpodcasts.com/cvd (http://journalclubpodcasts.com/cvd) to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit. In this Journal Club Podcast our faculty look at venous thrombosis appearing to be a complicated feature of Covid-19 and discuss treatments, including the role of direct oral anticoagulants in the pandemic of Covid-19.
Reach and audience
Public platform figures. Ratings count people who left a rating, not total listeners.
Apple Podcasts (US)
4.6 / 5
7 ratings
Podcast Authority Score: 15 / 100
A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.
Quality
17
Social presence
0
YouTube
0
Engagement
32
Contact Cardiology @Point of Care Podcasts
Guest appearances
Does not typically book guests
Based on episode analysis; this does not confirm that the show is currently accepting guests.
Host of Cardiology @Point of Care Podcasts?
Claim your podcast to manage its listing and keep your show details accurate.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
